Nemaura Medical Inc.
NMRD · OTC
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Revenue | $77 | $504 | $0 | $0 |
| % Growth | -84.7% | – | – | – |
| Cost of Goods Sold | $1,553 | $344 | $98 | $0 |
| Gross Profit | -$1,476 | $160 | -$98 | $0 |
| % Margin | -1,916.3% | 31.7% | – | – |
| R&D Expenses | $1,539 | $1,557 | $1,555 | $2,009 |
| G&A Expenses | $5,600 | $6,173 | $3,032 | $2,769 |
| SG&A Expenses | $5,600 | $6,173 | $3,032 | $2,769 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $980 | $0 | $0 | $0 |
| Operating Expenses | $8,119 | $7,730 | $4,587 | $4,778 |
| Operating Income | -$9,595 | -$7,570 | -$4,587 | -$4,778 |
| % Margin | -12,454.2% | -1,502.3% | – | – |
| Other Income/Exp. Net | -$4,549 | -$6,667 | -$2,008 | $4 |
| Pre-Tax Income | -$14,144 | -$14,237 | -$6,594 | -$4,775 |
| Tax Expense | $0 | -$350 | -$336 | -$614 |
| Net Income | -$14,144 | -$13,887 | -$6,259 | -$4,160 |
| % Margin | -18,358% | -2,755.8% | – | – |
| EPS | -0.57 | -0.59 | -0.28 | -0.2 |
| % Growth | 3.4% | -110.7% | -40% | – |
| EPS Diluted | -0.57 | -0.59 | -0.28 | -0.2 |
| Weighted Avg Shares Out | 24,878 | 23,384 | 22,283 | 20,806 |
| Weighted Avg Shares Out Dil | 24,878 | 23,384 | 22,283 | 20,806 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $2,008 | $4 |
| Interest Expense | $6,413 | $6,667 | $2,008 | $0 |
| Depreciation & Amortization | $444 | $230 | $98 | $55 |
| EBITDA | -$7,287 | -$7,341 | -$4,489 | -$4,724 |
| % Margin | -9,458.3% | -1,456.7% | – | – |